The Differential Impact of PTSD and Depression on HIV Disease Markers and Adherence to HAART in People Living with HIV
- 672 Downloads
Despite high rates of comorbidity, research has typically focused on the independent impact of posttraumatic stress disorder (PTSD) and depression symptoms in people living with HIV (PLWH). The present study examined the independent and comorbid influence of PTSD and depression symptoms on medication adherence, CD4 cell counts, and viral load, over the course of 3 months in 57 PLWH (82% men, 54% Caucasian, 44% African American) recruited from a clinic or social service agency. Both PTSD and depressive symptoms predicted lower subsequent adherence. However, only depressive symptoms predicted lower CD4 counts and presence of a detectable viral load. Participants reporting symptoms consistent with diagnostic levels of comorbid PTSD and depression were less likely to adhere to HAART and were more likely to have a detectable viral load. These results highlight the influences of PTSD and depression on adherence and HIV disease markers, and underscore the importance of examining comorbid symptomatology in PLWH.
KEY WORDS:HIV PTSD depression adherence CD4 viral load.
- American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
- Breslau, N., Davis, G., Andreski, P., Federman, B., and Anthony, J. (1998). Epidemiological findings on posttraumatic stress disorder and co-morbid disorders in the general population. In B. P. Dohrenwend (Ed.), Adversity, stress, & psychopathology (pp. 319–330). London: Oxford University Press.Google Scholar
- Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12 255–266.CrossRefPubMedGoogle Scholar
- Kuritzkes, D. R. (2001). Clinical implications for antiretroviral resistance. HIV Clinical Management, V13. Retrieved from http://www.medscape.comGoogle Scholar
- Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., and Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23 360–361.Google Scholar
- Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., and Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139 810–816.PubMedGoogle Scholar